Less Ads, More Data, More Tools Register for FREE

Pin to quick picksInternational Workplace Group Regulatory News (IWG)

Share Price Information for International Workplace Group (IWG)

Share Price is delayed by 15 minutes
Get Live Data
178.30    0.00 (0.00%)
Bid:
0.00
Ask:
195.00
Spread: 17.20 (9.674%)
Market Cap: £1.72b
IWG Live PriceLast checked at - London Stock Exchange

Intraday International Workplace Group Share Chart

Investor Day

5 Dec 2023 12:00

RNS Number : 7205V
IWG PLC
05 December 2023

5 December 2023

IWG ANNOUNCES RESUMPTION OF DIVIDEND AT ITS INVESTOR DAY FOLLOWING STRONG PERFORMANCE

IWG plc, the largest provider of hybrid workspace globally including its Regus and Spaces brands with an unrivalled network of 3,455 locations across more than 120 countries, hosts an Investor event for institutional investors and analysts today in New York City.

The presentations from IWG's management team will outline strategic priorities and prospects for the medium term; in addition to how we will deliver sustainable growth, cashflow, and maximize long-term shareholder returns.

This includes:

Β· Resumption of regular dividend payments

Β· A medium-term ambition of $1bn run-rate EBITDA1

Β· Committing to additional capital returns to shareholders once our net financial debt / EBITDA1 falls below 1x

Β· Presenting our business as three divisions - Managed and franchised, Company-owned, Worka

Mark Dixon, Chief Executive Officer and Charlie Steel, Chief Financial Officer, will be joined by members of the IWG Senior Leadership Team to present the business.

As part of this event, IWG will be outlining reporting going forward by focusing on three distinct, but complementary business models and presenting associated KPIs.

Focusing on growth through the capital-light business means that growth capex requirements will be dramatically lower in the future, generating more free cash flow for shareholders.

IWG is planning to restart its progressive dividend policy with a final dividend, expected to be 1p per share to be announced alongside 2023 FY results,

The Group is also announcing a medium-term EBITDA[1] ambition of $1bn EBITDA1 and that when 1x Net Debt / EBITDA1 is reached, IWG will share future cash flow between debt and equity holders. Until that point, the focus will remain on reducing net financial debt.

Mark Dixon, Founder and Chief Executive Officer, said: "I am delighted to be announcing the intention to resume the dividend which is a signal of how well the business is doing. We are delivering on our strategy of capital-light growth, backed up by having a strong balance sheet. We expect to continue to deliver both cashflow and growth, and I look forward to discussing the business's operations and financial targets further at our Investor event today in New York City."

As previously announced, IWG will be moving its functional currency to US dollars as of 1 January 2024 and the Board will finalise its review regarding a change of accounting standards to US GAAP in H1 2024.

IWG's outlook for full-year 2023 is reaffirmed from the Q3 trading update on 7 November 2023.

[1] Before the application of IFRS 16

Financial Calendar

5 March 2024 - 2023 FY Results (London, UK)

7 May 2024 - Q1 2024 Trading Update (Remote)

Further information

IWG plc

Mark Dixon, Chief Executive Officer

Charlie Steel, Chief Financial Officer

Richard Manning, Head of Investor Relations

Brunswick Tel: + 44 (0) 20 7404 5959

Nick Cosgrove

Peter Hesse

This update contains certain forward-looking statements with respect to the operations of IWG plc. These statements and forecasts involve risk and uncertainty because they relate to events and depend upon circumstances that may or may not occur in the future. There are a number of factors that could cause actual results or developments to differ materially from those expressed or implied by these forward-looking statements and forecasts. Nothing in this announcement should be construed as a profit forecast.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
UPDEANASEDXDFEA
Date   Source Headline
10th Jun 20267:00 amRNSTransaction in Own Shares
9th Jun 20267:00 amRNSTransaction in Own Shares
8th Jun 20267:00 amRNSTransaction in Own Shares
5th Jun 20267:00 amRNSTransaction in Own Shares
4th Jun 20267:00 amRNSTransaction in Own Shares
3rd Jun 20267:00 amRNSTransaction in Own Shares
2nd Jun 20265:00 pmRNSTotal Voting Rights: Month End Disclosure
2nd Jun 20267:00 amRNSTransaction in Own Shares
1st Jun 20267:00 amRNSTransaction in Own Shares
29th May 20267:00 amRNSTransaction in Own Shares
28th May 20267:00 amRNSTransaction in Own Shares
27th May 20267:00 amRNSTransaction in Own Shares
26th May 20267:00 amRNSTransaction in Own Shares
22nd May 20267:00 amRNSTransaction in Own Shares
21st May 20267:00 amRNSTransaction in Own Shares
20th May 20267:00 amRNSTransaction in Own Shares
19th May 20261:00 pmRNSResults of AGM
19th May 20267:00 amRNSTransaction in Own Shares
18th May 20267:00 amRNSTransaction in Own Shares
15th May 20267:00 amRNSTransaction in Own Shares
14th May 20267:00 amRNSTransaction in Own Shares
13th May 20267:00 amRNSTransaction in Own Shares
12th May 20267:00 amRNSFirst Quarter Trading Statement
12th May 20267:00 amRNSTransaction in Own Shares
11th May 20267:00 amRNSTransaction in Own Shares
8th May 20267:00 amRNSTransaction in Own Shares
7th May 20267:00 amRNSTransaction in Own Shares
6th May 20267:00 amRNSTransaction in Own Shares
5th May 20267:00 amRNSTransaction in Own Shares
1st May 20267:00 amRNSTransaction in Own Shares
30th Apr 20267:00 amRNSTransaction in Own Shares
29th Apr 20267:00 amRNSTransaction in Own Shares
28th Apr 20267:00 amRNSTransaction in Own Shares
27th Apr 20267:00 amRNSTransaction in Own Shares
24th Apr 20267:00 amRNSTransaction in Own Shares
23rd Apr 20267:00 amRNSTransaction in Own Shares
22nd Apr 20267:00 amRNSTransaction in Own Shares
21st Apr 20265:00 pmRNSDirector/PDMR Transaction
21st Apr 20267:00 amRNSTransaction in Own Shares
20th Apr 20267:00 amRNSTransaction in Own Shares
17th Apr 20267:00 amRNSTransaction in Own Shares
16th Apr 20263:00 pmRNSAnnual General Meeting 2026
16th Apr 20267:00 amRNSTransaction in Own Shares
15th Apr 20265:00 pmRNSDirector/PDMR Transaction
15th Apr 20267:00 amRNSTransaction in Own Shares
14th Apr 20267:00 amRNSTransaction in Own Shares
13th Apr 20267:00 amRNSTransaction in Own Shares
10th Apr 20267:00 amRNSTransaction in Own Shares
9th Apr 20267:00 amRNSTransaction in Own Shares
8th Apr 20265:00 pmRNSTotal Voting Rights: Month End Disclosure

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.